These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27569953)

  • 1. Sublingual Tacrolimus in Liver Transplantation: A Valid Option?
    Moreno Gonzales M; Myhre L; Taner T
    Transplant Proc; 2016; 48(6):2102-6. PubMed ID: 27569953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
    Nasiri-Toosi Z; Dashti-Khavidaki S; Nasiri-Toosi M; Khalili H; Jafarian A; Irajian H; Abdollahi A; Sadrai S
    Exp Clin Transplant; 2012 Dec; 10(6):586-91. PubMed ID: 22770208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study.
    Solari S; Cancino A; Wolff R; Norero B; Vargas JI; Barrera F; Guerra JF; Martínez J; Jarufe N; Soza A; Arrese M; Benitez C
    Aliment Pharmacol Ther; 2017 May; 45(9):1225-1231. PubMed ID: 28261844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution to twice daily bolus intravenous tacrolimus: optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant.
    Snell GI; Ivulich S; Mitchell L; Westall GP; Levvey BJ
    Ann Transplant; 2013 Aug; 18():399-407. PubMed ID: 23921892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients.
    Baccarani U; Velkoski J; Pravisani R; Adani GL; Lorenzin D; Cherchi V; Falzone B; Baraldo M; Risaliti A
    Transplant Proc; 2019 Nov; 51(9):2971-2973. PubMed ID: 31607620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis.
    Reams BD; Palmer SM
    Am J Respir Med; 2002; 1(2):91-8. PubMed ID: 14720063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Conversion From Twice-Daily Tacrolimus to Prolonged-Release Tacrolimus in Liver Transplantation: A Single-Center Experience.
    Ogura Y; Imai H; Kamei H; Hori T; Kurata N; Onishi Y
    Ann Transplant; 2016 Jul; 21():448-55. PubMed ID: 27432248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.
    Dumortier J; Guillaud O; Boillot O
    Liver Transpl; 2013 May; 19(5):529-33. PubMed ID: 23483701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.
    Uemoto S; Abe R; Horike H; So M
    Transplant Proc; 2014 Apr; 46(3):749-53. PubMed ID: 24767340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal initial dose of orally administered once-daily extended-release tacrolimus following intravenous tacrolimus therapy after liver transplantation.
    Mita A; Ikegami T; Masuda Y; Katsuyama Y; Ohno Y; Urata K; Nakazawa Y; Kobayashi A; Miyagawa S
    Transplant Proc; 2014 Apr; 46(3):794-6. PubMed ID: 24767351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual administration improves systemic exposure of tacrolimus in kidney transplant recipients: comparison with oral administration.
    Federico S; Carrano R; Sabbatini M; Nappi R; Russo L; Apicella L; Balletta MM; Santangelo M; Mosca T; Tarantino G; Capone D
    Eur J Clin Invest; 2016 Jul; 46(7):651-7. PubMed ID: 27240092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of Erythromycin to Increase Tacrolimus Concentrations in Liver Transplant Recipients.
    Chiang LH; Wu TH; Tsai TC; Lee WC
    Transplant Proc; 2019 Jun; 51(5):1439-1441. PubMed ID: 31155178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study.
    Collin C; Boussaud V; Lefeuvre S; Amrein C; Glouzman AS; Havard L; Billaud EM; Guillemain R
    Transplant Proc; 2010 Dec; 42(10):4331-7. PubMed ID: 21168693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of sublingual tacrolimus in lung transplant recipients.
    Watkins KD; Boettger RF; Hanger KM; Leard LE; Golden JA; Hoopes CW; Singer JP
    J Heart Lung Transplant; 2012 Feb; 31(2):127-32. PubMed ID: 22177691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
    Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
    Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
    McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
    Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients.
    Pennington CA; Park JM
    Am J Health Syst Pharm; 2015 Feb; 72(4):277-84. PubMed ID: 25631834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
    Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
    Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the conversion ratios for oral versus sublingual administration of tacrolimus in solid organ transplant recipients.
    Al Sagheer T; Enderby CY
    Clin Transplant; 2019 Oct; 33(10):e13727. PubMed ID: 31587353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.